Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

NICODERM CQ 7 MG/24HR PATCH

nicotine
$3.0900per EA
OTC

Strength

7 mg/24h

Manufacturer

Haleon US Holdings LLC

NDC

00135019602

Classification

Brand

Dosage Form

PATCH, EXTENDED RELEASE

Route

TRANSDERMAL

Last Updated

2/11/2019

Active Ingredients

NICOTINE

Approval Type

New Drug (NDA)

FDA Application

NDA020165

On Market Since

5/12/2011

Pharmacological Classes

Cholinergic Nicotinic Agonist
Nicotine

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+0.5%

Generic Alternatives

1 alternative • Same active ingredient

NICODERM CQ 7 MG/24HR PATCH
Brand
00135019605•Haleon US Holdings LLC
$3.0900

Related Drugs

Same classification

NICORETTE 4 MG LOZENGE
Brand
00135051101•Haleon US Holdings LLC
$0.4023
per EA
NICORETTE 4 MG LOZENGE
Brand
00135051106•Haleon US Holdings LLC
$0.4023
per EA
NICORETTE 4 MG LOZENGE
Brand
00135051107•Haleon US Holdings LLC
$0.4023
per EA
NICORETTE 2 MG CHEWING GUM
Brand
00135015707•Haleon US Holdings LLC
$0.4055
per EA
NICORETTE 2 MG CHEWING GUM
Brand
00135015710•Haleon US Holdings LLC
$0.4055
per EA
NICORETTE 2 MG CHEWING GUM
Brand
00135015711•Haleon US Holdings LLC
$0.4055
per EA
NICORETTE 2 MG CHEWING GUM
Brand
00135022905•Haleon US Holdings LLC
$0.4055
per EA
NICORETTE 2 MG CHEWING GUM
Brand
00135024102•Haleon US Holdings LLC
$0.4055
per EA
NICORETTE 2 MG CHEWING GUM
Brand
00135024105•Haleon US Holdings LLC
$0.4055
per EA
NICORETTE 2 MG CHEWING GUM
Brand
00135024106•Haleon US Holdings LLC
$0.4055
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy